Papillary muscle scarring (papSCAR) is prevalent in one-third of DCM patients and predicts cardiac death independently. The FIDDLE technique significantly improves papSCAR detection sensitivity ...
ImmunityBio Inc. (NASDAQ:IBRX) is one of the most buzzing stocks to buy with the highest upside potential. On March 9, ...
Papillary muscle scarring in DCM patients is associated with higher risks of cardiac death, heart failure, and arrhythmia events. Microvascular dysfunction is a strong predictor of poor prognosis, ...
The combination of nogapendekin alfa inbakicept-pmln (Anktiva) and Bacillus Calmette-Guérin was added to the NCCN clinical ...
NCCN has added ImmunityBio's ANKTIVA to its Clinical Practice Guidelines for BCG-unresponsive non muscle invasive bladder cancer with papillary only disease. This update extends recognized use of ...
TCT 1019: Complex degenerative mitral valve disease with a posterior cleft and severe regurgitation successfully treated using a single PASCAL Ace device with horizontal positioning. Receive the the ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Study honoraria to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results